Loading page…
Healthcare
Boston Scientific Corporation records an AlphaScore of 69/100, reflecting a watch signal with a grade of B in the healthcare sector as of October 11, 2026. Key fundamentals feature a gross margin of 69.01% and a net margin of 17.5%. A primary strength is its strong revenue growth of 19.87% alongside a high safety sub-score of 80 and minimal leverage with a debt-to-equity of 0.01. A key risk is its low momentum sub-score of 13. Evidence is strictly limited to the supplied dataset.
Written 11/10/2026, 00:38:35 UTC · Snapshot 11/10/2026